FDA
-
-
-
-
-
-
-
Assembly Biosciences Reports Third Quarter 2020 Financial Results and Business Update
-
-
-
-
-
-
-
Assembly Biosciences Announces FDA Fast Track Designation Granted to ABI-H2158 for the Treatment of Chronic Hepatitis B Virus Infection
-
-
-
-
-
-
-
Data for Assembly Biosciences’ First and Second Generation HBV Core Inhibitors in Development for the Treatment of Chronic Hepatitis B Highlighted in Late-Breaker Poster Session at AASLD 2019
-
-
-
-
-
-
-
Assembly Biosciences Reports First Quarter 2019 Financial Results and Recent Highlights
-
-
-
-
-
-
-
Assembly Biosciences Announces Oral Presentation at 2018 AASLD
-
-
-
-
-
-
-
Allergan (AGN) Enters Licensing Agreement with Assembly Biosciences (ASMB) to Obtain Worldwide Rights to GI Programs
-
-
323,577 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

